Search


      

Search Result: Showing 11 to 17 of 17 results for keyword: "Prostate cancer"

28 June 2022

Eighty percent of men diagnosed with prostate cancer will end up with erectile dysfunction after treatment (Downing et al, 2019). Yet, talking about sex, treating erectile dysfunction, and meeting the man’s needs after treatment is often lower down on the healthcare professional’s agenda. Prostate Cancer UK found that sex and erectile dysfunction is the biggest unmet need for men with prostate cancer.

More details

28 June 2022

Eighty percent of men diagnosed with prostate cancer will end up with erectile dysfunction after treatment (Downing et al, 2019). Yet, talking about sex, treating erectile dysfunction, and meeting the man’s needs after treatment is often lower down on the healthcare professional’s agenda. Prostate Cancer UK found that sex and erectile dysfunction is the biggest unmet need for men with prostate cancer.

More details

08 February 2022

Meg Burgess is a Specialist Nurse at Prostate Cancer UK, providing support and information to anyone diagnosed with or concerned about a prostate problem via telephone, email, and live chat services. In this article, Meg talks about  why fatigue support is needed, how it is delivered at Prostate Cancer UK, and the small changes men can make to help reduce the impact of fatigue on their quality of life.

More details

03 October 2025

A number of areas of the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summary on Prostate Cancer have been updated in light of new research. Make sure you know what the latest recommendations mean for your patients. 

More details

03 December 2021

As Specialist Nurses at Prostate Cancer UK, we provide information and support to thousands of men living with and concerned about prostate cancer.

More details

13 November 2025

New guidance from NICE (the National Institute for Health and Care Excellence) gives another treatment option for people with hormone-sensitive metastatic prostate cancer for whom docetaxel is not suitable. The guidance discusses the use of darolutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer. 

More details

08 November 2022

Scott Newman, a specialist nurse from Prostate Cancer UK, discusses why an accurate and reliable test to detect prostate cancer is needed.   

More details